# OpGen to acquire Curetis GmbH in business combination

OpGen, Inc. entered a definitive agreement to acquire Curetis GmbH, a wholly-owned subsidiary of Curetis N.V., creating a transatlantic diagnostics company. The combined company will be headquartered in Gaithersburg, MD, USA.

- Type: Acquisition
- Announced: 2019-09-04
- Where: Gaithersburg, MD, United States
- Status: announced
- Products: molecular diagnostics, bioinformatics
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [OpGen](https://endata.com/companies/41870.md) (acquirer)
- [Curetis](https://endata.com/companies/41871.md) (target)

## Sources

- [globenewswire.com](https://www.globenewswire.com/news-release/2019/09/04/1910618/0/en/curetis-and-opgen-enter-into-definitive-agreement-to-combine-businesses.html), 2019-09-04: "The combination will create a transatlantic, U.S.-headquartered and Nasdaq-listed company with an innovative commercial-stage molecular diagnostics and bioinformatics franchise."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.